The price action is very similar to last summer after the ASCO meeting. Potential updates are:
1. Announcement that trial enrollment is complete - price impact neutral
2. Announcement that 222 events have occurred and committee has agreed to let the trial continue - price drops huge
3. Announcement that 222 events have occurred and target OS has been achieved - BOOM
I believe we will hear #1 followed by #2 but hoping for #3.
It had a huge run-up with no pull-back, well here it is. Now a bunch of investors that were waiting on the sidelines are looking to get in for the next leg up in a couple of weeks. The fact that July is coming up with no interim analysis yet is very bullish.
There are many comments on Twitter about coming 1st interim look,
I guess the 1st look timing of results may be leaked. Very strange
that PIII trial information was updated today at ClinicalTrials.gov, but
I can not see any changes showing up so far. The stock action today
plus update at ClinicalTrials.gov tell me some kind of news is coming